220 related articles for article (PubMed ID: 35904193)
1. Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.
Zhao Y; Li L; Lu Z; Hu Y; Zhang H; Sun F; Li Q; He C; Shu W; Wang L; Cao T; Luo Z; Yan Z; Liu D; Gao P; Zhu Z
J Am Heart Assoc; 2022 Aug; 11(15):e025328. PubMed ID: 35904193
[TBL] [Abstract][Full Text] [Related]
2. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na
Kravtsova O; Bohovyk R; Levchenko V; Palygin O; Klemens CA; Rieg T; Staruschenko A
Am J Physiol Renal Physiol; 2022 Jun; 322(6):F692-F707. PubMed ID: 35466690
[TBL] [Abstract][Full Text] [Related]
3. High-salt intake increases TRPC3 expression and enhances TRPC3-mediated calcium influx and systolic blood pressure in hypertensive patients.
Hu Y; Xia W; Li Y; Wang Q; Lin S; Wang B; Zhou C; Cui Y; Jiang Y; Pu X; Wei X; Wu H; Zhang H; Zhu Z; Liu D; Li Z
Hypertens Res; 2020 Jul; 43(7):679-687. PubMed ID: 32037396
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats.
Wang B; Xiong S; Lin S; Xia W; Li Q; Zhao Z; Wei X; Lu Z; Wei X; Gao P; Liu D; Zhu Z
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711865
[TBL] [Abstract][Full Text] [Related]
5. Canagliflozin and irbesartan ameliorate renal fibrosis via the TGF-β1/Smad signaling pathway in Dahl salt-sensitive rats.
Zhai J; Wang Z; Zhang T; He L; Ma S; Zuo Q; Zhang G; Wang X; Guo Y
J Int Med Res; 2023 Oct; 51(10):3000605231206289. PubMed ID: 37862678
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats.
Ito H; Okamoto R; Ali Y; Zhe Y; Katayama K; Ito M; Dohi K
J Hypertens; 2022 May; 40(5):956-968. PubMed ID: 35285452
[TBL] [Abstract][Full Text] [Related]
7. Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress.
Wang Z; Zhai J; Zhang T; He L; Ma S; Zuo Q; Zhang G; Wang Y; Guo Y
Biochem Biophys Res Commun; 2023 Apr; 653():53-61. PubMed ID: 36857900
[TBL] [Abstract][Full Text] [Related]
8. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle.
Iwamoto T; Kita S; Zhang J; Blaustein MP; Arai Y; Yoshida S; Wakimoto K; Komuro I; Katsuragi T
Nat Med; 2004 Nov; 10(11):1193-9. PubMed ID: 15475962
[TBL] [Abstract][Full Text] [Related]
9. Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.
Kimura Y; Kuno A; Tanno M; Sato T; Ohno K; Shibata S; Nakata K; Sugawara H; Abe K; Igaki Y; Yano T; Miki T; Miura T
J Diabetes Investig; 2019 Jul; 10(4):933-946. PubMed ID: 30663266
[TBL] [Abstract][Full Text] [Related]
10. TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction.
Ma T; Lin S; Wang B; Wang Q; Xia W; Zhang H; Cui Y; He C; Wu H; Sun F; Zhao Z; Gao P; Zhu Z; Liu D
Biochem Biophys Res Commun; 2019 Nov; 519(4):674-681. PubMed ID: 31543348
[TBL] [Abstract][Full Text] [Related]
11. K
Zietara A; Palygin O; Levchenko V; Dissanayake LV; Klemens CA; Geurts A; Denton JS; Staruschenko A
Am J Physiol Renal Physiol; 2023 Aug; 325(2):F177-F187. PubMed ID: 37318990
[TBL] [Abstract][Full Text] [Related]
12. Caffeine intake antagonizes salt sensitive hypertension through improvement of renal sodium handling.
Yu H; Yang T; Gao P; Wei X; Zhang H; Xiong S; Lu Z; Li L; Wei X; Chen J; Zhao Y; Arendshorst WJ; Shang Q; Liu D; Zhu Z
Sci Rep; 2016 May; 6():25746. PubMed ID: 27173481
[TBL] [Abstract][Full Text] [Related]
13. Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats.
He L; Zuo Q; Ma S; Zhang G; Wang Z; Zhang T; Zhai J; Guo Y
Ren Fail; 2024 Dec; 46(1):2300314. PubMed ID: 38189082
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors.
Wilcox CS
Hypertension; 2020 Apr; 75(4):894-901. PubMed ID: 32114848
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between plasma membrane Na(+)/Ca (2+) exchanger-1 and TRPC/Orai-containing channels: key players in arterial hypertension.
Pulina MV; Zulian A; Baryshnikov SG; Linde CI; Karashima E; Hamlyn JM; Ferrari P; Blaustein MP; Golovina VA
Adv Exp Med Biol; 2013; 961():365-74. PubMed ID: 23224895
[TBL] [Abstract][Full Text] [Related]
16. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
Reed JW
Vasc Health Risk Manag; 2016; 12():393-405. PubMed ID: 27822054
[TBL] [Abstract][Full Text] [Related]
17. Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats.
Liu D; Yang D; He H; Chen X; Cao T; Feng X; Ma L; Luo Z; Wang L; Yan Z; Zhu Z; Tepel M
Hypertension; 2009 Jan; 53(1):70-6. PubMed ID: 19029480
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
[TBL] [Abstract][Full Text] [Related]
19. Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension.
Iwamoto T
Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R536-45. PubMed ID: 16467501
[TBL] [Abstract][Full Text] [Related]
20. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
